Stock Events

Stock Events

BioCorRx 

$0.4
7
+$0+0% Monday 20:00

Statistics

Day High
0.4
Day Low
0.4
52W High
0.5
52W Low
0.2
Volume
567
Avg. Volume
4,795
Mkt Cap
9.47M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11MayExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.07
-0.07
-0.06
-0.06
Expected EPS
-0.06
Actual EPS
N/A

Financials

-63,825%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
16,000Revenue
-10.21MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BICX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alkermes
ALKS
Mkt Cap5.07B
Alkermes plc develops treatments for addiction, including alcohol dependence, competing directly with BioCorRx's addiction treatment solutions.
Indivior Pharmaceuticals
INDV
Mkt Cap3.67B
Indivior PLC offers products for opioid addiction treatment, directly competing with BioCorRx's approach to addiction recovery.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.83B
ACADIA Pharmaceuticals Inc. develops therapies for central nervous system disorders, which can include addiction treatment, overlapping with BioCorRx's market.
Novartis
NVS
Mkt Cap237.61B
Novartis AG, through its broad range of pharmaceuticals, indirectly competes in the addiction treatment space, potentially overlapping with BioCorRx's offerings.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division, offers a wide range of healthcare products that can compete with BioCorRx's addiction treatment solutions.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. has a diverse portfolio of healthcare products, including treatments that could compete with BioCorRx's addiction recovery programs.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. provides various healthcare solutions and treatments, including those for addiction, potentially competing with BioCorRx's offerings.

About

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.
Show more...
CEO
Ms. Lourdes Felix
Employees
3
Country
US
ISIN
US09073C2052

Listings

OTC Link
US
BICX

0 Comments

Share your thoughts

FAQ

What is BioCorRx stock price today?▼
The current price of BICX is $0.4 USD — it has increased by +0% in the past 24 hours. Watch BioCorRx stock price performance more closely on the chart.
What is BioCorRx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BioCorRx stocks are traded under the ticker BICX.
Is BioCorRx stock price growing?▼
BICX stock has risen by +0% compared to the previous week, the month change is a +56.86% rise, over the last year BioCorRx has showed a +14.29% increase.
What is BioCorRx market cap?▼
Today BioCorRx has the market capitalization of 9.47M
When is the next BioCorRx earnings date?▼
BioCorRx is going to release the next earnings report on May 11, 2026.
What is BioCorRx revenue for the last year?▼
BioCorRx revenue for the last year amounts to 16,000 USD.
What is BioCorRx net income for the last year?▼
BICX net income for the last year is -10.21M USD.
How many employees does BioCorRx have?▼
As of April 04, 2026, the company has 3 employees.
In which sector is BioCorRx located?▼
BioCorRx operates in the Health Care sector.
When did BioCorRx complete a stock split?▼
The last stock split for BioCorRx was on January 22, 2019 with a ratio of 1:100.
Where is BioCorRx headquartered?▼
BioCorRx is headquartered in Anaheim, US.